miR-466c

N/A

Report date: 2025/12/12 17:32:15

Base Information

Drug NamemiR-466c
Drug Alias NameVEGFA gene therapy (University Of Eastern Finland/RNatives)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionVascular endothelial growth factor gene transference
TargetsVascular endothelial growth factor
Therapy Area/IndicationsPeripheral Vascular DiseasesMyocardial IschemiaCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFinland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Eastern Finland
China Registration ClassN/A

Develop Information

Active CompaniesRNatives IncUniversity Of Eastern Finland
Inactive CompaniesN/A
Active IndicationsPeripheral Vascular DiseasesMyocardial Ischemia
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A